Christopher Rentsch is an associate professor and pharmacoepidemiologist with over a decade of experience building and analyzing large-scale cohorts and biobanks from electronic health records across the UK and US. Based in London with joint affiliation at Yale School of Medicine, he focuses on real-world pharmacogenomics and drug repurposing for substance misuse, translating observational data into actionable clinical and public health insights. He directs long-standing courses in pharmacoepidemiology and pharmacovigilance at LSHTM and serves on the Board of the International Society for Pharmacoepidemiology, combining rigorous methods with education and policy engagement. Trained with a PhD from LSHTM and an MPH from Emory, he blends quantitative epidemiology with practical drug-safety applications and a track record of building reproducible large-EHR research platforms.
11 years of coding experience
Doctor of Philosophy - PhD, Epidemiology and Population Health, Doctor of Philosophy - PhD, Epidemiology and Population Health at London School of Hygiene and Tropical Medicine, U. of London
Master of Public Health - MPH, Global Epidemiology, Master of Public Health - MPH, Global Epidemiology at Rollins School of Public Health at Emory University
Bachelor of Arts - BA, Sociology, Bachelor of Arts - BA, Sociology at The Ohio State University
Study to examine the relationship between ethnicity and adverse covid outcomes in England
Contributions:1 release, 5 reviews, 24 commits in 2 months
examineethnicityrelationshipadverseengland
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.